Korean name: 난소화성말토덱스트린. This page reports what South Korea's
Ministry of Food and Drug Safety has approved for this ingredient.
MFDS recognition no.
2004-9
Approval route
Notified (고시형) — listed in MFDS public standards
Daily intake (as approved)
‘난소화성말토덱스트린’로서
Approval holder
한국마쯔다니(주)
Approved functional claim (Korean original)
The text below is the approved wording as published by MFDS. It is reproduced without
modification. Any translation is provided for comprehension only and carries no regulatory
standing.
"난소화성말토덱스트린은 식사와 함께 섭취하면 당의 흡수를 억제시켜 식후 혈당 조절에 도움을 줄 수 있습니다."
◆ 인체시험에서 난소화성말토덱스트린을 식사와 함께 섭취할 경우 당의 흡수를 억제시켜 식후 혈당 조절에 도움을 줄 수 있음을 확인하였으나 자료의 수가 제한되어 있음. 따라서 반드시 ‘---에 도움을 줄 수 있습니다’의 형식으로 표시하여야 함.
Precautions (Korean original)
◆ 난소화성말토덱스트린은 당뇨병의 치료 및 예방에 사용될 수 없으므로 당뇨병 치료가 필요한 경우에는 의사와 상담 하에 사용하여야 합니다.
What this means for sourcing
An ingredient approved in Korea is not automatically permitted elsewhere. Importers should
verify status with their own authority. Conversely, Korean approval demonstrates that a dossier
on safety and function was reviewed under a national regulatory system, which many buyers treat
as a meaningful signal.
Regulatory approvals described on this page were issued by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and are valid in South Korea only. They are not health claims in your jurisdiction and have not been evaluated by the FDA, EFSA, or any other authority. This page reports regulatory facts; it does not recommend or endorse any product.